SCHEMBL27424230

SCHEMBL27424230

CC(C)(C)NC(CCCCNC(=O)C(C)(C)C)C(=O)C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ DRD4 P21917 10/20 0.35
▸ DRD2 P14416 9/20 0.35
▸ EPHX1 P07099 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ FOLH1 Q04609 1/20 0.34
▸ CA12 O43570 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA3 P07451 1/20 0.33
▸ CA4 P22748 1/20 0.33
▸ CA6 P23280 1/20 0.33
▸ CA5A P35218 1/20 0.33
▸ CA7 P43166 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ CA14 Q9ULX7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19483316 0.89 ALDH1A1 (0.55) POLBALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL19483325 0.89 ALDH1A1 (0.55) POLBALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL19483324 0.87 KDM4E (0.48) ALDH1A1SMN1; SMN2EPHX1KDM4EFOLH1
SCHEMBL13671361 0.87 POLB (0.41) POLBALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL19483322 0.87 KDM4E (0.48) ALDH1A1SMN1; SMN2EPHX1KDM4EFOLH1
SCHEMBL24591799 0.85 SIRT6 (0.35) MEN1KMT2AEPHX1KDM4EFOLH1
SCHEMBL27016037 0.84 KMT2A (0.39) ALDH1A1MEN1KMT2ADRD4DRD2
SCHEMBL19483312 0.83 KISS1R (0.39) EPHX1
SCHEMBL13166779 0.83 POLB (0.35) POLB
SCHEMBL19483326 0.83 KISS1R (0.39) EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240218011-A1 GLUCOCORTICOID RECEPTOR AGONISTS AND CONJUGATES THEREOF FIREFLY BIO, INC. 2024-07-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240218011-A1 GLUCOCORTICOID RECEPTOR AGONISTS AND CONJUGATES THEREOF NR3C1, NR3C2, MC2R POLB 3279/4885ALDH1A1 3778/4885SMN1; SMN2 3733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback